top of page
How the New Executive Order on Drug Pricing Could Impact Clinical Trials and Comparator Sourcing
Earlier this month, the US President signed a landmark executive order aimed at delivering “most favored nation” (MFN) pricing for...
Clinical Services International (CSI)
Jun 10
Navigating Trump-Era Tariffs
CSI’s Strategic Approach to Mitigating Clinical Trial Supply Disruption Recent developments in U.S. trade policy are shaking up supply...
Clinical Services International (CSI)
Apr 25
News and Insights
.png){kind=logo}
bottom of page